BioPharma Credit grows capital raising to $305m
BioPharma Credit, the UK closed-end investment fund that provides debt funding to the life sciences industry, has priced its latest capital raise, growing the deal to $305m.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: